| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
300.33(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
| Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
| Total People Sold |
2 |
9 |
9 |
12 |
| Total Sell Transactions |
2 |
11 |
13 |
29 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hurwich Thomas A. |
VP, Controller |
• – – |
2017-02-28 |
4 |
D |
$62.22 |
$307,802 |
D/D |
(4,947) |
62,329 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2017-02-28 |
4 |
S |
$61.89 |
$143,031 |
D/D |
(2,311) |
67,276 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2017-02-28 |
4 |
D |
$62.22 |
$2,213,974 |
D/D |
(35,583) |
147,825 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
43,022 |
192,466 |
|
- |
|
| Severino Michael |
EVP, R&D and CSO |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
49,548 |
192,830 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,816 |
107,395 |
|
- |
|
| Richmond Timothy J. |
SVP, Human Resources |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,816 |
67,431 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
42,249 |
183,408 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,138 |
69,587 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
137,448 |
463,614 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-02-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,415 |
326,166 |
|
- |
|
| Gosebruch Henry O |
Chief Strategy Officer |
• – – |
2016-12-09 |
4 |
D |
$60.90 |
$844,744 |
D/D |
(13,871) |
77,179 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2016-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,840 |
334,581 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2016-12-02 |
4 |
S |
$59.19 |
$390,654 |
D/D |
(6,600) |
172,370 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2016-12-02 |
4 |
OE |
$27.29 |
$180,114 |
D/D |
6,600 |
178,970 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2016-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,979 |
141,159 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2016-11-16 |
4 |
S |
$62.00 |
$192,200 |
D/D |
(3,100) |
61,449 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2016-11-16 |
4 |
OE |
$28.86 |
$89,475 |
D/D |
3,100 |
64,549 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2016-09-07 |
4 |
S |
$65.00 |
$3,250,000 |
D/D |
(50,000) |
144,138 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2016-08-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
755 |
61,449 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2016-06-24 |
4 |
S |
$60.00 |
$11,171,173 |
D/D |
(186,106) |
194,138 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2016-06-24 |
4 |
OE |
$24.21 |
$5,140,971 |
D/D |
186,106 |
380,244 |
|
- |
|
| Severino Michael |
EVP, R&D and CSO |
• – – |
2016-06-02 |
4 |
D |
$62.83 |
$1,355,494 |
D/D |
(21,574) |
143,282 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2016-06-02 |
4 |
S |
$63.80 |
$18,249,712 |
D/D |
(285,953) |
338,421 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2016-06-02 |
4 |
A |
$35.88 |
$10,259,994 |
D/D |
285,953 |
624,374 |
|
- |
|
765 Records found
|
|
Page 22 of 31 |
|
|
1.09 (0.65%) 
